Miguel Calado
Miguel Calado
Chairman
Read more
Miguel Calado
Miguel Calado
Chairman

Born 1955. Dual citizen of Portugal and the United States of America. Chairman of the Board since 2020, member of the Board of Directors since 2019. Independent of the company and significant shareholders.

Education: Bachelor of Business Administration degree in Accounting from the Catholic University of Brazil. Owner/President Management program in General Management at Harvard Business School.

Experience: Mr. Calado has, among others, served as a member of the Board of Directors of Aveleda S.A. and OutSystems S.A. He has been President of iMAX Diagnostic Imaging Business Unit, Vice President of Hovione S.A., Vice President and CFO of Hovione S.A. Additionally, Mr. Calado has held various positions at PepsiCo, Inc. including Vice President and CFO of PepsiCo Foods International.

Other current positions of trust: Mr. Calado is the President of Gamcal LLC, Chairman of the Board of Directors of Wygroup, S.A, Chairman of the Supervisory Board of OutSystems S.A. and a member of the Board of Directors of HNI Corporation.

Holdings in the company: 0 shares and 250,000 stock options, entitling to same amount of shares in the company.

Mads Laustsen
Mads Laustsen
Vice Chairman
Read more
Mads Laustsen
Mads Laustsen
Vice Chairman

Born 1957. Danish citizen. Vice Chairman of the Board of Directors since 2020, member of the Board of Directors since 2019. Independent of the company and significant shareholders.

Education: Bachelor of Science degree in biochemical engineering from the Danish Technical University.

Experience: Mr. Laustsen has, among others, served as Chief Manufacturing Officer of Symphogen A/S, Chief Science Officer and member of the Board of Directors of CMC Biologics A/S (now AGC Biologics A/S), and CEO of CMC Biologics A/S.

Other current positions of trust: Mr. Laustsen is the co-founder and CEO of Bactolife ApS and member of the Board of Directors of Synklino ApS.

Holdings in the company: 0 shares and 200,000 stock options, entitling to same amount of shares in the company.

Albert Hæggström
Albert Hæggström
Board Member
Read more
Albert Hæggström
Albert Hæggström
Board Member

Born 1971. Finnish citizen. Member of the Board of Directors since 2015, CFO and a member of the Management Team since 2018. Not independent of the company nor significant shareholders.

Education: Bachelor of Science degree in economics from Hanken School of Economics in Helsinki.

Experience: Mr. Hæggström has, among others, served as Head of Equities at Bank of Åland Plc, Head of Equities at Alfred Berg Kapitalförvaltning Ab, and Portfolio Manager at Alfred Berg Kapitalförvaltning Finland Ab.

Other current positions of trust: Mr. Hæggström is CFO and a member of the Management Team of Nanoform.

Holdings in the company: 692,000 shares and 200,000 stock options, entitling to same amount of shares in the company.

Cynthia Schwalm
Cynthia Schwalm
Board Member
Read more
Cynthia Schwalm
Cynthia Schwalm
Board Member

Born 1960. Citizen of the United States of America. Board member since September 2020. Independent of the company and its significant shareholders.

Education: Cynthia holds a B.S. degree in nursing from the University of Delaware and an Executive Master of Business Administration from the Wharton School of Business from the University of Pennsylvania in Philadelphia, PA.

Experience: Cynthia began her career as an Oncology and Critical Care Nurse at the Albert Einstein Medical Center & Rutgers University Camden Medical Center, where she developed a patient-focused perspective. She has executive experience from Ipsen, Inc., Eisai, Inc., Amgen, Inc., and Johnson & Johnson, Inc. She is also an experienced independent board member for many notable biotech and pharma companies. Cynthia previously served on the Women’s Leadership Advisory Board at Harvard University’s Kennedy School of Government for nearly a decade.

Other current positions of trust: Currently a non-executive Director at Caladrius Biosciences Inc., Kadmon Group and G1 Therapeutics Inc. Wharton Business School Leadership Advisor since 2016.

Holdings in the company: 0 shares and 59,726 stock options, entitling her to the same amount of shares in the company.